Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030

AstraZeneca CEO Pascal Soriot discussed his company's ambitious revenue goal with CNBC's Jim Cramer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.